🔎 Trials Near Me

Home › Cardiovascular Disease › Alabama

Cardiovascular Disease clinical trials in Alabama

22 studies for Cardiovascular Disease are looking for participants at sites in Alabama.

Cities in Alabama

A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

  • Heart Center Research, LLC, Huntsville
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 30, 2026 · NCT07783802

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

  • Pinnacle Research Group, LLC, Anniston
  • Eastern Shore Research Group, Fairhope
  • Lakeview Clinical Research, Guntersville
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 30, 2026 · NCT07064473

Adapting a Stress Management Intervention to Reduce Cardiovascular Disease Risk

  • University of Alabama at Birmingham, Birmingham
Recruiting
Ages 18 and older · Women · Updated Sep 28, 2026 · NCT06811896

Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention

  • Advanced Cardiovascular LLC, Alexander City
  • Cardiology, PC, Birmingham
  • Heart Center Research, LLC, Huntsville
RecruitingPhase 4
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT06909565

Product Surveillance Registry

  • Birmingham
  • Huntsville
RecruitingObservational study
All ages · All sexes · Updated Sep 18, 2026 · NCT01524276

Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease

  • Clinical Trial Site, Birmingham
  • Clinical Trial Site, Birmingham
  • Clinical Trial Site, Fairhope
  • and 4 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 18, 2026 · NCT07181109

Zenith® Fenestrated+ Clinical Study

  • University of Alabama Birmingham Hospital, Birmingham
Recruiting
Ages 18 and older · All sexes · Updated Sep 17, 2026 · NCT04875429

Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.

  • University of Alabama Birmingham (UAB) Hospital, Birmingham
Recruiting
Ages 18 and older · All sexes · Updated Sep 15, 2026 · NCT03242642

Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure

  • University of Alabama at Birmingham Hospital, Birmingham
Recruiting
Ages 18 to 100 · All sexes · Updated Sep 9, 2026 · NCT06310031

An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)

  • SEC Clinical Research LLC, Andalusia
  • Heart Center Research Llc, Huntsville
  • Mobile Heart Specialists, Mobile
RecruitingPhase 3
Ages 18 to 100 · All sexes · Updated Sep 4, 2026 · NCT07517263

Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults

  • University of Alabama at Birmingham, Birmingham
  • Birmingham VA, Birmingham
RecruitingPhase 4Healthy volunteers welcome
Ages 75 and older · All sexes · Updated Sep 1, 2026 · NCT04262206

A Study About How Blood Cell Growth Patterns Relate to Heart Health After Treatment for Hodgkin Lymphoma

  • USA Health Strada Patient Care Center, Mobile
RecruitingObservational study
Ages 7 and older · All sexes · Updated Aug 25, 2026 · NCT05705531

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

  • Research Site, Athens
  • Research Site, Birmingham
  • Research Site, Birmingham
  • and 8 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 24, 2026 · NCT07000357

OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events

  • Advanced Cardiovascular LLC, Alexander City
  • University of Alabama Birmingham Saint Vincents Birmingham, Birmingham
  • Birmingham Clinical Research, Birmingham
  • and 4 more
RecruitingPhase 3
Ages 50 to 105 · All sexes · Updated Aug 21, 2026 · NCT07136012

Improving Patient-Centered Care for Underserved Older African American Patients With Cardiovascular Comorbidities

  • Cooper Green Mercy Hospital, Birmingham
RecruitingObservational study
Ages 50 to 99 · All sexes · Updated Aug 6, 2026 · NCT07748858

NAUTICAL: Effect of Natriuretic Peptide Augmentation on Cardiometabolic Health in Black Individuals

  • University of Alabama at Birmingham, Birmingham
RecruitingPhase 2Healthy volunteers welcome
Ages 18 and older · All sexes · Updated Jul 28, 2026 · NCT04055428

Pivotal Study for the Cardiac Performance System (CPS)

  • Huntsville Hospital Heart Center, Huntsville
RecruitingObservational study
Ages 18 and older · All sexes · Updated Apr 24, 2026 · NCT06870591

GENESIS: Genotype Guided - Natriuretic Peptides - Cardiometabolic Health Study

  • University of Alabama at Birmingham, Birmingham
RecruitingHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Apr 9, 2026 · NCT05216042

PRECISION-BP: Precision Chronopharamacotherapy Targeting NP-RAAS-BP Rhythm Axis

  • University of Alabama at Birmingham, Birmingham
RecruitingPhase 2/3Healthy volunteers welcome
Ages 18 and older · All sexes · Updated Apr 9, 2026 · NCT04971720

CARBON: UAB Cardiovascular Research Biobank

  • University of Alabama at Birmingham, Birmingham
RecruitingObservational studyHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Feb 13, 2026 · NCT05067231

Inspire HER: Inspiring the Heart and Emotions for Radical Health

  • University of Alabama at Birmingham, Birmingham
Recruiting
Ages 30 to 79 · Women · Updated Dec 29, 2025 · NCT06966258

MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions

  • Cardiology, PC - Princeton Baptist Medical Center, Birmingham
Recruiting
Ages 18 to 110 · All sexes · Updated Feb 25, 2025 · NCT05908331

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.